Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of a Novel Antipsychotic ITI-007 in Schizophrenia
This study is currently recruiting participants.
Verified January 2012 by Intra-Cellular Therapies, Inc.
Study NCT01499563   Information provided by Intra-Cellular Therapies, Inc.

First Received on December 16, 2011.   Last Updated on January 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
ITI-007
Placebo
Risperidone
Additional drug interventions recognized in this trial
Antipsychotic Agents
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Intra-Cellular Therapies, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services